# OnCo record nct05503888 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05503888/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05503888", "NCT05503888" ;
  schema:name "Phase Ib/II Study of Almonertinib Combined With SHR-1701 in the Treatment of Relapsed or Advanced Non-small Cell Lung Cancer"@en ;
  schema:description "A phase 1/2 trial of aumolertinib and retlirafusp alfa in lung cancer, run by Suzhou Suncadia Biopharmaceuticals Co., Ltd., not yet recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05503888/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05503888> ;
  onco:status "planned" ;
  onco:tag "ctgov-ingest", "lung-deep-dive" ;
  onco:phase "1/2" ;
  onco:cancers <https://onco.cc/cancers/egfr-mutant-nsclc/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/aumolertinib/>, <https://onco.cc/drugs/retlirafusp-alfa/> .